Global Gravid Treatment Market Insights, Forecast to 2025
- QYR2786368
- 128 Pages
- October 2018
- Medical Devices
This report studies the global market size of Gravid Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gravid Treatment in these regions.
This research report categorizes the global Gravid Treatment market by top players/brands, region, type and end user. This report also studies the global Gravid Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Laboratoires Expanscience
Clarins Group
Merz North America, Inc. (Merz Group)
E.T. Browne Drug
Cynosure
Syneron Medical Ltd.
Union-Swiss (Pty) Ltd.
Basq Skincare
Ellipse A/S
The Boppy Company
Helix BioMedix
Weleda AG
Dermaclara
Mama Mio US
Centre Light Solutions
Market size by Product
Topical Products
Lasers
Microdermabrasion
Others
Market size by End User
Hospitals
Clinics
Specialty Dermatology Centers
Home-use
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Gravid Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Gravid Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Gravid Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Gravid Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Gravid Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Gravid Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Gravid Treatment Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Gravid Treatment Market Size Growth Rate by Product
1.4.2 Topical Products
1.4.3 Lasers
1.4.4 Microdermabrasion
1.4.5 Others
1.5 Market by End User
1.5.1 Global Gravid Treatment Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Specialty Dermatology Centers
1.5.5 Home-use
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gravid Treatment Market Size
2.1.1 Global Gravid Treatment Revenue 2013-2025
2.1.2 Global Gravid Treatment Sales 2013-2025
2.2 Gravid Treatment Growth Rate by Regions
2.2.1 Global Gravid Treatment Sales by Regions
2.2.2 Global Gravid Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Gravid Treatment Sales by Manufacturers
3.1.1 Gravid Treatment Sales by Manufacturers
3.1.2 Gravid Treatment Sales Market Share by Manufacturers
3.1.3 Global Gravid Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Gravid Treatment Revenue by Manufacturers
3.2.1 Gravid Treatment Revenue by Manufacturers (2013-2018)
3.2.2 Gravid Treatment Revenue Share by Manufacturers (2013-2018)
3.3 Gravid Treatment Price by Manufacturers
3.4 Gravid Treatment Manufacturing Base Distribution, Product Types
3.4.1 Gravid Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gravid Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Gravid Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Gravid Treatment Sales by Product
4.2 Global Gravid Treatment Revenue by Product
4.3 Gravid Treatment Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Gravid Treatment Breakdown Data by End User
6 North America
6.1 North America Gravid Treatment by Countries
6.1.1 North America Gravid Treatment Sales by Countries
6.1.2 North America Gravid Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Gravid Treatment by Product
6.3 North America Gravid Treatment by End User
7 Europe
7.1 Europe Gravid Treatment by Countries
7.1.1 Europe Gravid Treatment Sales by Countries
7.1.2 Europe Gravid Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gravid Treatment by Product
7.3 Europe Gravid Treatment by End User
8 Asia Pacific
8.1 Asia Pacific Gravid Treatment by Countries
8.1.1 Asia Pacific Gravid Treatment Sales by Countries
8.1.2 Asia Pacific Gravid Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Gravid Treatment by Product
8.3 Asia Pacific Gravid Treatment by End User
9 Central & South America
9.1 Central & South America Gravid Treatment by Countries
9.1.1 Central & South America Gravid Treatment Sales by Countries
9.1.2 Central & South America Gravid Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Gravid Treatment by Product
9.3 Central & South America Gravid Treatment by End User
10 Middle East and Africa
10.1 Middle East and Africa Gravid Treatment by Countries
10.1.1 Middle East and Africa Gravid Treatment Sales by Countries
10.1.2 Middle East and Africa Gravid Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Gravid Treatment by Product
10.3 Middle East and Africa Gravid Treatment by End User
11 Company Profiles
11.1 Laboratoires Expanscience
11.1.1 Laboratoires Expanscience Company Details
11.1.2 Company Business Overview
11.1.3 Laboratoires Expanscience Gravid Treatment Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Laboratoires Expanscience Gravid Treatment Products Offered
11.1.5 Laboratoires Expanscience Recent Development
11.2 Clarins Group
11.2.1 Clarins Group Company Details
11.2.2 Company Business Overview
11.2.3 Clarins Group Gravid Treatment Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Clarins Group Gravid Treatment Products Offered
11.2.5 Clarins Group Recent Development
11.3 Merz North America, Inc. (Merz Group)
11.3.1 Merz North America, Inc. (Merz Group) Company Details
11.3.2 Company Business Overview
11.3.Merz North America, Inc. (Merz Group) Gravid Treatment Sales, Revenue and Gross Margin (2013-2018)
11.3.4 Merz North America, Inc. (Merz Group) Gravid Treatment Products Offered
11.3.5 Merz North America, Inc. (Merz Group) Recent Development
11.4 E.T. Browne Drug
11.4.1 E.T. Browne Drug Company Details
11.4.2 Company Business Overview
11.4.3 E.T. Browne Drug Gravid Treatment Sales, Revenue and Gross Margin (2013-2018)
11.4.4 E.T. Browne Drug Gravid Treatment Products Offered
11.4.5 E.T. Browne Drug Recent Development
11.5 Cynosure
11.5.1 Cynosure Company Details
11.5.2 Company Business Overview
11.5.3 Cynosure Gravid Treatment Sales, Revenue and Gross Margin (2013-2018)
11.5.4 Cynosure Gravid Treatment Products Offered
11.5.5 Cynosure Recent Development
11.6 Syneron Medical Ltd.
11.6.1 Syneron Medical Ltd. Company Details
11.6.2 Company Business Overview
11.6.3 Syneron Medical Ltd. Gravid Treatment Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Syneron Medical Ltd. Gravid Treatment Products Offered
11.6.5 Syneron Medical Ltd. Recent Development
11.7 Union-Swiss (Pty) Ltd.
11.7.1 Union-Swiss (Pty) Ltd. Company Details
11.7.2 Company Business Overview
11.7.3 Union-Swiss (Pty) Ltd. Gravid Treatment Sales, Revenue and Gross Margin (2013-2018)
11.7.4 Union-Swiss (Pty) Ltd. Gravid Treatment Products Offered
11.7.5 Union-Swiss (Pty) Ltd. Recent Development
11.8 Basq Skincare
11.8.1 Basq Skincare Company Details
11.8.2 Company Business Overview
11.8.3 Basq Skincare Gravid Treatment Sales, Revenue and Gross Margin (2013-2018)
11.8.4 Basq Skincare Gravid Treatment Products Offered
11.8.5 Basq Skincare Recent Development
11.9 Ellipse A/S
11.9.1 Ellipse A/S Company Details
11.9.2 Company Business Overview
11.9.3 Ellipse A/S Gravid Treatment Sales, Revenue and Gross Margin (2013-2018)
11.9.4 Ellipse A/S Gravid Treatment Products Offered
11.9.5 Ellipse A/S Recent Development
11.10 The Boppy Company
11.10.1 The Boppy Company Company Details
11.10.2 Company Business Overview
11.10.3 The Boppy Company Gravid Treatment Sales, Revenue and Gross Margin (2013-2018)
11.10.4 The Boppy Company Gravid Treatment Products Offered
11.10.5 The Boppy Company Recent Development
11.11 Helix BioMedix
11.12 Weleda AG
11.13 Dermaclara
11.14 Mama Mio US
11.15 Centre Light Solutions
12 Future Forecast
12.1 Gravid Treatment Market Forecast by Regions
12.1.1 Global Gravid Treatment Sales Forecast by Regions 2018-2025
12.1.2 Global Gravid Treatment Revenue Forecast by Regions 2018-2025
12.2 Gravid Treatment Market Forecast by Product
12.2.1 Global Gravid Treatment Sales Forecast by Product 2018-2025
12.2.2 Global Gravid Treatment Revenue Forecast by Product 2018-2025
12.3 Gravid Treatment Market Forecast by End User
12.4 North America Gravid Treatment Forecast
12.5 Europe Gravid Treatment Forecast
12.6 Asia Pacific Gravid Treatment Forecast
12.7 Central & South America Gravid Treatment Forecast
12.8 Middle East and Africa Gravid Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gravid Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Gravid Treatment Product Picture
Table Gravid Treatment Market Segments
Table Key Manufacturers Gravid Treatment Covered
Table Global Gravid Treatment Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)
Figure Global Gravid Treatment Sales Market Share by Product 2013-2025
Figure Topical Products Product Picture
Table Major Manufacturers of Topical Products
Figure Lasers Product Picture
Table Major Manufacturers of Lasers
Figure Microdermabrasion Product Picture
Table Major Manufacturers of Microdermabrasion
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Gravid Treatment Market Size Growth Rate by End User 2018-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Specialty Dermatology Centers
Figure Home-use
Figure Others
Figure Gravid Treatment Report Years Considered
Figure Global Gravid Treatment Market Size 2013-2025 (Million US$)
Figure Global Gravid Treatment Sales 2013-2025 (K Units)
Table Global Gravid Treatment Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Gravid Treatment Sales by Regions 2013-2018 (K Units)
Table Global Gravid Treatment Sales Market Share by Regions 2013-2018
Figure Global Gravid Treatment Sales Market Share by Regions 2013-2018
Figure 2017 Global Gravid Treatment Sales Market Share by Regions
Table Global Gravid Treatment Revenue by Regions 2013-2018 (Million US$)
Table Global Gravid Treatment Revenue Market Share by Regions 2013-2018
Figure Global Gravid Treatment Revenue Market Share by Regions 2013-2018
Figure 2017 Global Gravid Treatment Revenue Market Share by Regions
Table Global Gravid Treatment Sales by Manufacturers (2013-2018) (K Units)
Table Global Gravid Treatment Sales Share by Manufacturers (2013-2018)
Figure Global Gravid Treatment Sales Share by Manufacturers in 2017
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Gravid Treatment Revenue by Manufacturers (2013-2018) (Million USD)
Table Gravid Treatment Revenue Share by Manufacturers (2013-2018)
Figure Gravid Treatment Value Share by Manufacturers in 2017
Table Key Manufacturers Gravid Treatment Price (2013-2018) (USD/Unit)
Table Gravid Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Gravid Treatment Product Type
Table Date of International Manufacturers Enter into Gravid Treatment Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Gravid Treatment Sales by Product (2013-2018) (K Units)
Table Global Gravid Treatment Sales Share by Product (2013-2018)
Figure Global Gravid Treatment Sales Market Share by Product (2013-2018)
Figure Global Gravid Treatment Sales Market Share by Product in 2017
Table Global Gravid Treatment Revenue by Product (2013-2018) (Million US$)
Table Global Gravid Treatment Revenue Share by Product (2013-2018)
Figure Global Gravid Treatment Revenue Market Share by Product (2013-2018)
Figure Global Gravid Treatment Revenue Market Share by Product in 2017
Table Gravid Treatment Price by Product 2013-2018 (USD/Unit)
Table Global Gravid Treatment Sales by End User (2013-2018) (K Units)
Table Global Gravid Treatment Sales Share by End User (2013-2018)
Figure Global Sales Gravid Treatment Market Share by End User (2013-2018)
Figure Global Sales Gravid Treatment Market Share by End User in 2017
Figure North America Gravid Treatment Sales Growth Rate 2013-2018 (K Units)
Figure North America Gravid Treatment Revenue Growth Rate 2013-2018 (Million US$)
Table North America Gravid Treatment Sales by Countries (2013-2018) (K Units)
Table North America Gravid Treatment Sales Market Share by Countries (2013-2018)
Figure 2017 North America Gravid Treatment Sales Market Share by Countries
Table North America Gravid Treatment Revenue by Countries (2013-2018) (Million US$)
Table North America Gravid Treatment Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Gravid Treatment Revenue Market Share by Countries
Figure United States Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure United States Gravid Treatment Revenue Growth Rate (2013-2018) (K Units)
Figure Canada Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Canada Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Mexico Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Table North America Gravid Treatment Sales by Product (2013-2018) (K Units)
Table North America Gravid Treatment Sales Market Share by Product (2013-2018)
Figure 2017 North America Gravid Treatment Market Share by Product
Table North America Gravid Treatment Sales by End User (2013-2018) (K Units)
Table North America Gravid Treatment Sales Market Share by End User (2013-2018)
Figure 2017 North America Gravid Treatment Market Share by End User
Figure Europe Gravid Treatment Sales Growth Rate 2013-2018 (K Units)
Figure Europe Gravid Treatment Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Gravid Treatment Sales by Countries (2013-2018) (K Units)
Table Europe Gravid Treatment Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Gravid Treatment Sales Market Share by Countries
Table Europe Gravid Treatment Revenue by Countries (2013-2018) (Million US$)
Table Europe Gravid Treatment Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Gravid Treatment Revenue Market Share by Countries
Figure Germany Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Germany Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure France Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure France Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure UK Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure UK Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Italy Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Italy Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Russia Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Russia Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Table Europe Gravid Treatment Sales by Product (2013-2018) (K Units)
Table Europe Gravid Treatment Sales Market Share by Product (2013-2018)
Figure 2017 Europe Gravid Treatment Market Share by Product
Table Europe Gravid Treatment Sales by End User (2013-2018) (K Units)
Table Europe Gravid Treatment Sales Market Share by End User (2013-2018)
Figure 2017 Europe Gravid Treatment Market Share by End User
Figure Asia Pacific Gravid Treatment Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Gravid Treatment Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Gravid Treatment Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Gravid Treatment Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Gravid Treatment Sales Market Share by Countries
Table Asia Pacific Gravid Treatment Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Gravid Treatment Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Gravid Treatment Revenue Market Share by Countries
Figure China Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure China Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Japan Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Korea Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure India Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure India Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Australia Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Singapore Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Singapore Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Table Asia Pacific Gravid Treatment Sales by Product (2013-2018) (K Units)
Table Asia Pacific Gravid Treatment Sales Market Share by Product (2013-2018)
Figure 2017 Asia Pacific Gravid Treatment Market Share by Product
Table Asia Pacific Gravid Treatment Sales by End User (2013-2018) (K Units)
Table Asia Pacific Gravid Treatment Sales Market Share by End User (2013-2018)
Figure 2017 Asia Pacific Gravid Treatment Market Share by End User
Figure Central & South America Gravid Treatment Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Gravid Treatment Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Gravid Treatment Sales by Countries (2013-2018) (K Units)
Table Central & South America Gravid Treatment Sales Market Share by Countries (2013-2018)
Figure 2017 Central & South America Gravid Treatment Sales Market Share by Countries
Table Central & South America Gravid Treatment Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Gravid Treatment Revenue Market Share by Countries (2013-2018)
Figure 2017 Central & South America Gravid Treatment Revenue Market Share by Countries
Figure Brazil Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Argentina Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Argentina Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Table Central & South America Gravid Treatment Sales by Product (2013-2018) (K Units)
Table Central & South America Gravid Treatment Sales Market Share by Product (2013-2018)
Figure 2017 Central & South America Gravid Treatment Market Share by Product
Table Central & South America Gravid Treatment Sales by End User (2013-2018) (K Units)
Table Central & South America Gravid Treatment Sales Market Share by End User (2013-2018)
Figure 2017 Central & South America Gravid Treatment Market Share by End User
Figure Middle East and Africa Gravid Treatment Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Gravid Treatment Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Gravid Treatment Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Gravid Treatment Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Gravid Treatment Sales Market Share by Countries
Table Middle East and Africa Gravid Treatment Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Gravid Treatment Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Gravid Treatment Revenue Market Share by Countries
Figure GCC Countries Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Turkey Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Turkey Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure Egypt Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Figure South Africa Gravid Treatment Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Gravid Treatment Revenue Growth Rate (2013-2018) (Million US$)
Table Middle East and Africa Gravid Treatment Sales by Product (2013-2018) (K Units)
Table Middle East and Africa Gravid Treatment Sales Market Share by Product (2013-2018)
Figure 2017 Middle East and Africa Gravid Treatment Market Share by Product
Table Middle East and Africa Gravid Treatment Sales by End User (2013-2018) (K Units)
Table Middle East and Africa Gravid Treatment Sales Market Share by End User (2013-2018)
Figure 2017 Middle East and Africa Gravid Treatment Market Share by End User
Table Laboratoires Expanscience Company Details
Table Laboratoires Expanscience Gravid Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Laboratoires Expanscience Recent Development
Table Clarins Group Company Details
Table Clarins Group Gravid Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Clarins Group Recent Development
Table Merz North America, Inc. (Merz Group) Company Details
Table Merz North America, Inc. (Merz Group) Gravid Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merz North America, Inc. (Merz Group) Recent Development
Table E.T. Browne Drug Company Details
Table E.T. Browne Drug Gravid Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table E.T. Browne Drug Recent Development
Table Cynosure Company Details
Table Cynosure Gravid Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Cynosure Recent Development
Table Syneron Medical Ltd. Company Details
Table Syneron Medical Ltd. Gravid Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Syneron Medical Ltd. Recent Development
Table Union-Swiss (Pty) Ltd. Company Details
Table Union-Swiss (Pty) Ltd. Gravid Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Union-Swiss (Pty) Ltd. Recent Development
Table Basq Skincare Company Details
Table Basq Skincare Gravid Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Basq Skincare Recent Development
Table Ellipse A/S Company Details
Table Ellipse A/S Gravid Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Ellipse A/S Recent Development
Table The Boppy Company Company Details
Table The Boppy Company Gravid Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table The Boppy Company Recent Development
Table Helix BioMedix Company Details
Table Weleda AG Company Details
Table Dermaclara Company Details
Table Mama Mio US Company Details
Table Centre Light Solutions Company Details
Table Global Gravid Treatment Sales Forecast by Regions 2018-2025 (K Units)
Table Global Gravid Treatment Sales Market Share Forecast by Regions 2018-2025
Table Global Gravid Treatment Revenue Forecast by Regions 2018-2025 (Million US$)
Table Global Gravid Treatment Revenue Market Share Forecast by Regions 2018-2025
Table Global Gravid Treatment Sales Forecast by Product 2018-2025 (K Units)
Table Global Gravid Treatment Sales Market Share Forecast by Product 2018-2025
Table Global Gravid Treatment Revenue Forecast by Product 2018-2025 (Million US$)
Table Global Gravid Treatment Revenue Market Share Forecast by Product 2018-2025
Table Global Gravid Treatment Sales Forecast by End User 2018-2025 (K Units)
Table Global Gravid Treatment Sales Market Share Forecast by End User 2018-2025
Figure North America Gravid Treatment Sales Growth Rate Forecast (2018-2025) (K Units)
Figure North America Gravid Treatment Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Europe Gravid Treatment Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Europe Gravid Treatment Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Asia Pacific Gravid Treatment Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Asia Pacific Gravid Treatment Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Central & South America Gravid Treatment Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Central & South America Gravid Treatment Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Middle East and Africa Gravid Treatment Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Middle East and Africa Gravid Treatment Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Table Gravid Treatment Value Chain
Table Gravid Treatment Customers List
Table Gravid Treatment Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
